A match between binding to β-adrenoceptors and stimulation of adenylyl cyclase parameters of (-)isoproterenol and salbutamol on rat brain

Pharmacological Research

Volumn 35, Issue 4, 1997, Pages 303-312

  Garnier, Vincent ^a   Zini, Roland ^a   Sapena, Rosa ^a   Tillement, Jean Paul ^a  

^a FACULTÉ DE MÉDECINE   (France)

Author keywords

Adenylyl cyclase; G protein; Isoproterenol; Rat brain; Salbutamol; adrenergic receptors

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADENYLATE CYCLASE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BRONCHODILATING AGENT; CYCLIC AMP; ISOPRENALINE; SALBUTAMOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; BRAIN SYNAPTOSOME; CEREBELLUM; DISSOCIATION CONSTANT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031126324     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0141     Document Type: Article

References (32)

1. De Lean A, Stadel JM, Lefkowitz RJ. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupledβ J Biol Chem. 225:1980;7108-7117.
2. Levitski A, Marbach I, Bar-Sinai A. The signal transduction betweenβ Life Sci. 52:1993;2093-2100.
3. Rasenick MM, Watanabe M, Lazarevic MB, Hatta S, Hamm HE. Synthetic peptides as probes for G protein function. J Biol Chem. 269:1994;21519-21525.
4. Stadel JM, Lefkowitz RJ. β-adrenergic receptors: identification and characterization by radioligand binding studies. Theβ-Adrenergic Receptors. 1991;The Humana Press Inc. Clifton.
5. Fillenz M. Central noradrenergic neurons. Noradrenergic Neurons. 1990;Cambridge University Press, Cambridge.
6. 2. Biochem Pharmacol. 37:1988;1145-1151.
7. O'Donnell JM, Wolfe BB, Frazer A. Agonist interactions withβ J Pharmacol Exp Ther. 228:1984;640-647.
8. 2s. Mol Pharmacol. 41:1993;889-893.
9. 2. Proc Natl Acad Sci USA. 90:1993;10798-10802.
10. Ciman M, Rascio N, Pozza D, Sartorelli L. Synaptosome-free rat brain mitochondria preparation: an improved method. Neurosci Res Commun. 11:1992;87-92.
11. 3125. J Receptor Res. 112:1992;369-387.
12. Salomon Y. Adenylate cyclase assay. Brooker G, Greengard P, Robison GA. Advances in Cyclic Nucleotide Research. 1979;Raven Press, New York.
13. Morin D, Zini R, Querol-Ferrer V, Sapena R, Tillement J-P. A method to measure simultaneously cyclic AMP and inositol phosphate accumulation in rat brain slices. J Neurochem. 56:1991;1114-1120.
14. I50. Biochem Pharmacol. 22:1973;3099-3108.
15. 2. J Pharmacol Exp Ther. 241:1987;187-195.
16. 2. Eur J Pharmacol. 130:1986;137-139.
17. 2. Mol Pharmacol. 16:1979;34-46.
18. 1. Biochem Pharmacol. 31:1982;1743-1747.
19. Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homcy CJ, Vatner SF, Vatner DE. Myocardialβ J Clin Invest. 91:1993;907-914.
20. Severne Y, Ijzerman A, Nerme V, Timmerman H, Vauquelin G. Shallow agonist competition curves forβ Mol Pharmacol. 31:1987;69-73.
21. Sapena R, Morin D, Zini R, Tillement J-P. Isoproterenol interacts differently withβ Biochem Pharmacol. 47:1994;175-178.
22. 2. Life Sci. 52:1993;2145-2160.
23. 2. J Pharmacol Exp Ther. 261:1992;248-270.
24. 2. Naunyn-Schmiedebergs Arch Pharmacol. 331:1985;60-70.
25. 35. Proc Natl Acad Sci USA. 92:1995;7242-7246.
26. 35. Mol Pharmacol. 47:1995;848-854.
27. 35. Mol Pharmacol. 44:1993;115-123.
28. Arango V, Ernsberger P, Reis DJ, Mann JJ. Demonstration of high- and low-affinityβ Brain Res. 516:1990;113-121.
29. s. Mol Pharmacol. 45:1995;772-778.
30. Vickroy TW, Yamamura HI, Roeske WR. Differential regulation of high-affinity agonist binding to muscarinic sites in the rat heart, cerebellum, and cerebral cortex. Biochem Biophys Res Commun. 116:1993;284-290.
31. s. J Pharmacol Exp Ther. 252:1990;1341-1346.
32. Kenakin T, Morgan P, Lutz M. On the importance of the 'antagonist assumption' to how receptors express themselves. Biochem Pharmacol. 50:1995;17-26.